Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-26
1996-02-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546146, 546147, 546194, 546198, 546199, 546207, 546225, 546227, 546281, 548159, 5483061, 548527, 548530, 548531, 540596, 540597, 540602, 540610, 514212, 514318, 514321, 514322, 514330, 514343, 514367, 514394, 514423, 514326, C07D21712, C07D40108, A61K 3147
Patent
active
054911494
ABSTRACT:
This invention relates to substituted dihydroxypropylamines, a process to prepare intermediates useful for the synthesis of these compounds, compositions comprising such compounds, and a method of treating retroviral infection.
REFERENCES:
patent: 5294720 (1994-03-01), Jadhav et al.
Boudreaux Gerald L.
Davis Zinna N.
Ivy C. Warren
Kondrad Karen H.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Dihydroxypropylamine containing retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroxypropylamine containing retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroxypropylamine containing retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240782